Skip to content

Efficacy and Safety of Pulsed Radiofrequency Combined with Nerve Block in the Treatment of Thoracic and Costal Postherpetic Neuralgia: A Randomized Controlled Clinical Trial

Efficacy and Safety of Pulsed Radiofrequency Combined with Nerve Block in the Treatment of Thoracic and Costal Postherpetic Neuralgia: A Randomized Controlled Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122013
Enrollment
Unknown
Registered
2026-04-08
Start date
2026-04-10
Completion date
Unknown
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postherpetic neuralgia

Interventions

Intervention group:Thoracic spinal nerve root block combined with pulsed radiofrequency modulation
Control group:Pulsed radiofrequency modulation alone

Sponsors

The 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1) Meet the diagnostic criteria for PHN: herpes zoster course >=1 month and VAS score >=40 points at the time of visit; 2) Age >=18 years and <=85 years; 3) Herpetic skin lesions located in the thoracic spinal nerve innervation area (T1-T12); involving <=4 segments; 4) No prior treatment with PRF, nerve block, or other minimally invasive interventional therapies before enrollment; 5) Agree to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1) Patients with severe cardiopulmonary insufficiency, severe hepatic or renal insufficiency, or hematological disorders; 2) Patients with skin lesions or local infection at the puncture site; 3) Patients with poorly controlled diabetes (fasting blood glucose >=10.0 mmol/L); 4) Patients with abnormal coagulation function; 5) Patients with allergy to local anesthetics or other drugs used in this study, or those otherwise unsuitable for nerve block; 6) Pregnant or lactating women; 7) Patients with psychiatric disorders or cognitive dysfunction who cannot adequately understand the study assessment scales.

Design outcomes

Primary

MeasureTime frame
Postoperative pain VAS score at 1 month;

Secondary

MeasureTime frame
Changes in pain at 1 day, 1 week, 1 month, and 3 months postoperatively;Inflammatory indicators;Insomnia Severity Index, ISI;Patient Health Questionnaire-9, PHQ-9;Generalized Anxiety Disorder-7, GAD-7;Postoperative complications and adverse reactions;Dosage of analgesic drugs and remedial drugs;

Countries

China

Contacts

Public ContactWang Yingfeng

The 940th Hospital of Joint Logistic Support Force of Chinese People's Liberation Army

wyft2006@sina.com+86 139 1991 7116

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 17, 2026